PUS1 Gene Mitochondrial Myopathy and Sideroblastic Anemia Type 1 Genetic Test
Components
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Dysmorphology
Doctor
Pediatrics
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for PUS1 Gene Mitochondrial Myopathy and Sideroblastic Anemia Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PUS1 Gene Mitochondrial Myopathy and Sideroblastic Anemia Type 1 NGS Genetic DNA Test gene PUS1
Test Details
The PUS1 gene is responsible for providing instructions to produce a protein called pseudouridine synthase 1. This protein is involved in the modification of RNA molecules, specifically the conversion of uridine to pseudouridine. Pseudouridine is a modified nucleotide found in RNA molecules that helps in maintaining the structure and stability of RNA.
Mutations in the PUS1 gene can lead to a condition called mitochondrial myopathy and sideroblastic anemia type 1. Mitochondrial myopathy refers to a group of disorders that affect the mitochondria, which are the powerhouses of the cell responsible for producing energy. Sideroblastic anemia is a condition characterized by an inability of the body to produce healthy red blood cells due to problems with iron metabolism.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. It involves sequencing the DNA or RNA of an individual to identify any mutations or variations in the genes of interest. In the case of PUS1 gene-related disorders, NGS genetic testing can be used to identify any mutations in the PUS1 gene that may be causing mitochondrial myopathy and sideroblastic anemia type 1. This can help in confirming the diagnosis, providing information about disease progression, and guiding treatment options.
Test Name | PUS1 Gene Mitochondrial myopathy and sideroblastic anemia type 1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PUS1 Gene Mitochondrial myopathy and sideroblastic anemia type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PUS1 Gene Mitochondrial myopathy and sideroblastic anemia type 1 NGS Genetic DNA Test gene PUS1 |
Test Details |
The PUS1 gene is responsible for providing instructions to produce a protein called pseudouridine synthase 1. This protein is involved in the modification of RNA molecules, specifically the conversion of uridine to pseudouridine. Pseudouridine is a modified nucleotide found in RNA molecules that helps in maintaining the structure and stability of RNA. Mutations in the PUS1 gene can lead to a condition called mitochondrial myopathy and sideroblastic anemia type 1. Mitochondrial myopathy refers to a group of disorders that affect the mitochondria, which are the powerhouses of the cell responsible for producing energy. Sideroblastic anemia is a condition characterized by an inability of the body to produce healthy red blood cells due to problems with iron metabolism. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. It involves sequencing the DNA or RNA of an individual to identify any mutations or variations in the genes of interest. In the case of PUS1 gene-related disorders, NGS genetic testing can be used to identify any mutations in the PUS1 gene that may be causing mitochondrial myopathy and sideroblastic anemia type 1. This can help in confirming the diagnosis, providing information about disease progression, and guiding treatment options. |